🇺🇸 FDA
Pipeline program

Total Neoadjuvant Treatment

MA-BTC-II-002

Phase 2 small_molecule active

Quick answer

Total Neoadjuvant Treatment for Biliary Tract Neoplasms is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Biliary Tract Neoplasms
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials